Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Vardenafil

A phosphodiesterase type 5 (PDE5) inhibitor for erectile dysfunction, approved in Europe in March 2003 and in the United States the same year; it is also available as orodispersible tablets. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?Its structure is almost a twin of sildenafil's: the two molecules differ in the position of a single nitrogen atom and in an ethyl group in place of a methyl.

VardenafilGo to the active ingredient →
VardenafilActive ingredientVardenafilCat. No. P-V018-001CAS 224785-90-4
Vardenafil-d5Isotopically labelledVardenafil-d5Cat. No. P-V018-013CAS 1189685-70-8

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.